Significant changes to the levels of A-to-I editing of Alu repetitive elements owing to the ADAR1 and ADAR2 enzymes expression were first identified in brain, oesophageal, breast, prostate, lung, kidney, and testis tumours in a transcriptome-wide RNA editing analysis [123,124,125]. This evidence concerns the gene ADAR and neoplasm.